Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comprehensive analysis of EphA2 in pan-cancer: A prognostic biomarker associated with cancer immunity.

Clinical and experimental pharmacology & physiology - 1 Aug 2024

Li Yuchun, Fei Hanxiao, Xiao Zhiwen, Lu Xiuxia, Zhang Hua, Liu Mengmeng

Abstract excerpt

BACKGROUND: Several studies have reported a significant relationship between Ephrin receptor A2 (EphA2) and malignant progression in numerous cancers. However, there is a lack of comprehensive pan-cancer analysis on the prognostic value, mutation status, methylation landscape, and potential immunological function of EphA2. METHOD: Using The Cancer Genome Atlas, Genotype Tissue Expression Database and GEO data, we...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Cell Line, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cell Proliferation

Share to DNA Methylation

Share to Gene Expression Regulation, Neoplastic

Share to Mutation

Share to Neoplasms

Share to Prognosis

Source

Identifiers

PMID: 38886133
DOI: 10.1111/1440-1681.13902

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comprehensive analysis of EphA2 in pan-cancer: A prognostic biomarker associated with cancer immunity.PMID 38886133Read ↗

Systematic Pan-Cancer Analysis Reveals the Prognostic Value and Immunological Role of EPHX2Semantic proximity Read ↗

Molecular Characteristics and Prognostic Role of EPHA2 in Human Tumors via Pan-cancer AnalysisSemantic proximity Read ↗

EPHA7 mutation as a predictive biomarker for immune checkpoint inhibitors in multiple cancers.Semantic proximity Read ↗

EphA2 Receptor Tyrosine Kinase as a Promising Target for Cancer TherapeuticsSemantic proximity Read ↗

EPHA5 mutations predict survival after immunotherapy in lung adenocarcinoma.Semantic proximity Read ↗

Multiomics characteristics and immunotherapeutic potential of EZH2 in pan-cancerSemantic proximity Read ↗

A comprehensive prognostic and immunological analysis of ephrin family genes in hepatocellular carcinomaSemantic proximity Read ↗

ANXA2 is a potential biomarker for cancer prognosis and immune infiltration: A systematic pan-cancer analysisSemantic proximity Read ↗

EFNA4 as a potential prognostic biomarker and therapeutic target for GBMLGGSemantic proximity Read ↗

Insights Into the Prognostic Value and Immunological Role of NAAA in Pan-Cancer.Semantic proximity Read ↗

Up-regulation of EphA2 and down-regulation of EphrinA1 are associated with the aggressive phenotype and poor prognosis of malignant glioma.Semantic proximity Read ↗

Pan-Cancer Analysis Reveals Prognostic Potential of ANGPTL2 and Its Implications in Tumor MicroenvironmentSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.